activity
20152026
most citedSurvival analysis under non-proportional hazards: investigating non-inferiority or equivalence in time-to-event data

3 citations · 4 across the 9 of their papers we have counts for

collaborators
Showing stat.MEShow all

7 papers · 1 filter

stat.ME2026

A Better Comparison under right-censoring: ABC Statistic for Equivalence Testing and Quantification

Simon Mack, Kathrin Möllenhoff, Dennis Dobler

The ABC (area between curves) statistic is an -distance which targets an easy-to-interpret estimand. Defined as the (normalized) integrated absolute distance between two survi…

stat.ME2026

Estimating effect thresholds and beyond: A flexible framework for multivariate alert detection

Lucia Ameis, Niklas Hagemann, Kathrin Möllenhoff

Evaluating the influence of continuous covariates, like exposure time or dose, on a response variable is a pivotal objective in the assessment of a compound's effect, particularly…

stat.ME2025

Capturing heterogeneous time-variation in covariate effects in non-proportional hazard regression models

Niklas Hagemann, Thomas Kneib, Kathrin Möllenhoff

A central focus in survival analysis is examining how covariates influence survival time. These covariate effects are often found to be either time-varying, heterogeneous - such as…

stat.ME2024

Identification of changes in gene expression

Lucia Ameis, Kathrin Möllenhoff

Evaluating the change in gene expression is a common goal in many research areas, such as in toxicological studies as well as in clinical trials. In practice, the analysis is often…

stat.ME2020★ 3 cited

Survival analysis under non-proportional hazards: investigating non-inferiority or equivalence in time-to-event data

Kathrin Möllenhoff, Achim Tresch

The classical approach to analyze time-to-event data, e.g. in clinical trials, is to fit Kaplan-Meier curves yielding the treatment effect as the hazard ratio between treatment gro…

stat.ME2019★ 1 cited

Equivalence tests for binary efficacy-toxicity responses

Holger Dette, Kathrin Möllenhoff, Frank Bretz

Clinical trials often aim to compare a new drug with a reference treatment in terms of efficacy and/or toxicity depending on covariates such as, for example, the dose level of the…

stat.ME2015

Equivalence of dose response curves

Holger Dette, Kathrin Möllenhoff, Stanislav Volgushev +1

This paper investigates the problem whether the difference between two parametric models describing the relation between a response variable and several covariates in two…